Witnessing the stock’s movement on the chart, on Wednesday, IGM Biosciences Inc (NASDAQ: IGMS) had a quiet start as it plunged -5.93% to $1.27, before settling in for the price of $1.35 at the close. Taking a more long-term approach, IGMS posted a 52-week range of $0.92-$22.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 7.57% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 7.57%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 49.04%. This publicly-traded company’s shares outstanding now amounts to $34.67 million, simultaneously with a float of $16.71 million. The organization now has a market capitalization sitting at $76.35 million. At the time of writing, stock’s 50-day Moving Average stood at $1.2384, while the 200-day Moving Average is $5.0590.
IGM Biosciences Inc (IGMS) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. IGM Biosciences Inc’s current insider ownership accounts for 72.20%, in contrast to 26.12% institutional ownership. According to the most recent insider trade that took place on Jun 16 ’25, this organization’s PRINCIPAL ACCOUNTING OFFICER sold 486 shares at the rate of 1.20, making the entire transaction reach 583 in total value, affecting insider ownership by 26,530. Preceding that transaction, on Jun 16 ’25, Company’s CHIEF FINANCIAL OFFICER sold 1,522 for 1.20, making the whole transaction’s value amount to 1,825. This particular insider is now the holder of 178,802 in total.
IGM Biosciences Inc (IGMS) Earnings and Revenue Records
IGM Biosciences Inc’s EPS increase for this current 12-month fiscal period is 49.04% and is forecasted to reach -1.40 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 20.64% through the next 5 years, which can be compared against the 7.57% growth it accomplished over the previous five years trading on the market.
IGM Biosciences Inc (NASDAQ: IGMS) Trading Performance Indicators
Let’s observe the current performance indicators for IGM Biosciences Inc (IGMS). It’s Quick Ratio in the last reported quarter now stands at 5.71. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 28.49.
In the same vein, IGMS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.28, a figure that is expected to reach -0.23 in the next quarter, and analysts are predicting that it will be -1.40 at the market close of one year from today.
Technical Analysis of IGM Biosciences Inc (IGMS)
Going through the that latest performance of [IGM Biosciences Inc, IGMS]. Its last 5-days volume of 0.63 million indicated improvement to the volume of 0.47 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 46.94% While, its Average True Range was 44.98%.
Raw Stochastic average of IGM Biosciences Inc (IGMS) in the period of the previous 100 days is set at 62.50%, which indicates a major rise in contrast to 61.29% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0543 that was lower than 0.0908 volatility it exhibited in the past 100-days period.
